Pengembangan dan Validasi Metode Bioanalisis Trimetoprim dalam Sampel Plasma dan Urin Manusia Simulasi Menggunakan KCKT-PDA

  • Dion Notario Program Studi Sarjana Farmasi, Fakultas Kedokteran dan Ilmu Kesehatan, Universitas Katolik Indonesia Atma Jaya, Jakarta, Indonesia
  • Jessica Amelia
  • Genoveva Della
Keywords: Trimethoprim, HPLC-PDA, Urine, Plasma, Bioanalytical method validation

Abstract

To monitor trimethoprim levels (TMP) in humans, a validated, simple, and cost-efficient analytical method is needed to be applied regularly. However, most of the methods used to establish TMP levels in urine and plasma use complex instrumentation. Therefore, in this study, a simpler High-Performance Liquid Chromatography-based (HPLC) method was developed. The separation was carried out using a GIST® C18 column (150 × 4.6 mm, 5 μm) at a temperature of 35°C which was fed by a mobile phase in the form of an acetic acid solution pH 2.5: acetonitrile (87:13, v / v) at a speed of 1.4 ml/min. Detection was performed with Photodiode Array Detector (PDA) at wavelengths of 254 nm and 243 nm to quantify TMP in urine and plasma samples respectively. The preparation of urine and plasma sequentially was carried out by the liquid-liquid extraction (ECC) method using ethyl acetate and the protein precipitation using acetonitrile. This method proved to be selective, linear (R=0.997), accurate with %error ≤ 10.29% at LLOQ level and above LLOQ value %error ≤ 10.45%, precision with %RSD ≤ 11.79% at LLOQ level and %RSD ≤ 10.82% above LLOQ. In addition, this method is quite sensitive for pharmacokinetic studies in the urine and monitoring of TMP levels in the blood with LLOQ 5 mg/L in both urine and plasma. The stability of trimethoprim in solution, urine, and plasma was conducted to ensure storage time. The developed method is proven to be valid and can be applied in pharmacokinetic studies and monitoring of trimethoprim drug levels in urine and plasma.

References

Castiglione V, Cavalier E, Gadisseur R. Clinical data on rare Sulfamethoxazole crystalluria assessed by Fourier transform infrared spectrophotometry. Data Brief. 2018;21:2033-2036. doi: 10.1016/j.dib.2018.11.006.

Caron F, Wehrle V, Etienne M. The comeback of trimethoprim in France. Medecine et maladies infectieuses. 2017;47(4):253–60. doi:10.1016/j.medmal.2016.12.001.

Heudorf U, Weindel M, Wagenlehner F. Antibiotic resistance and antibiotic consumption in a region-using the example of community-acquired urinary tract infections. Aktuelle Urologie. 2021; doi: 10.1055/a-1468-8212.

Ahmed H, Farewell D, Jones HM, Francis NA, Paranjothy S, Butler CC. Antibiotic prophylaxis and clinical outcomes among older adults with recurrent urinary tract infection: cohort study. Age and ageing. 2019;48(2):228–34. doi: 10.1093/ageing/afy146.

Hampton T, Whitehall E, Beasley C, Stevens K, Lowe N, Hogg E, et al. Recurrent acute otitis media: a survey of current management in England. The Journal of Laryngology & Otology. 2021;135(10):855–7. doi: 10.1017/S0022215121001924.

Soudais B, Ribeaucoup F, Schuers M. Guidelines for the management of male urinary tract infections in primary care: a lack of international consensus-a systematic review of the literature. Family Practice. 2022 :cmac068. doi: 10.1093/fampra/cmac068.

More AS, Bhange NR, Gadekar KG, Kulkarni SG. Trimethoprim-induced hyperkalemia in renal transplant recipient. Indian Journal of Transplantation. 2018;12(2):149. doi: 10.4103/ijot.ijot_4_18.

Yokoyama S, Nakagawa J, Aiuchi N, Seito T, Niioka T. Impact of trimethoprim on serum creatinine, sodium, and potassium concentrations in patients taking trimethoprim‐sulfamethoxazole without changes in glomerular filtration rate. Journal of Clinical Pharmacy and Therapeutics. 2022; doi: 10.1111/jcpt.13679.

Crellin E, Mansfield KE, Leyrat C, Nitsch D, Douglas IJ, Root A, et al. Trimethoprim use for urinary tract infection and risk of adverse outcomes in older patients: cohort study. British Medical Journal. 2018;360. doi: 10.1136/bmj.k341.

Rajput J, Moore LS, Mughal N, Hughes S. Evaluating the risk of hyperkalaemia and acute kidney injury with cotrimoxazole: a retrospective observational study. Clinical Microbiology and Infection. 2020;26(12):1651–7. doi: 10.1016/j.cmi.2020.02.021.

El-Najjar N, Hösl J, Holzmann T, Jantsch J, Gessner A. UPLC-MS/MS method for therapeutic drug monitoring of 10 antibiotics used in intensive care units. Drug Testing and Analysis. 2018;10(3):584-591. doi: 10.1002/dta.2253.

Fatica E, Faber J, Gaffron C, Bjergum M, Langman L, Jannetto P. Quantification of Serum Sulfamethoxazole and Trimethoprim by Ultra-fast Solid-Phase Extraction-Tandem Mass Spectrometry. Theraputic Drug Monitoring. 2020;42(5):724-732. doi: 10.1097/FTD.0000000000000785.

Rehm S, Rentsch KM. LC-MS/MS method for nine different antibiotics. Clinica Chimica Acta. 2020;511:360–7. doi: 10.1016/j.cca.2020.11.001.

Hruska MW, Frye RF. Determination of trimethoprim in low-volume human plasma by liquid chromatography. Journal of Chromatography B. 2004;807(2):301–5. doi: 10.1016/j.jchromb.2004.04.021.

Liu L, Wan Q, Xu X, Duan S, Yang C. Combination of micelle collapse and field-amplified sample stacking in capillary electrophoresis for determination of trimethoprim and sulfamethoxazole in animal-originated foodstuffs. Food Chemistry. 2017;219:7-12. doi: 10.1016/j.foodchem.2016.09.118.

Food and Drug Administration. Bioanalytical method validation guidance for industry. US Department of Health and Human Services 2018.

Kaza M, Karaźniewicz-Łada M, Kosicka K, Siemiątkowska A, Rudzki PJ. Bioanalytical method validation: new FDA guidance vs. EMA guideline. Better or worse? Journal of Pharmaceutical and Biomedical Analysis. 2019;165:381-385. doi: 10.1016/j.jpba.2018.12.030.

International Conference on Harmonization. ICH guideline M10 on bioanalytical method validation and study sample analysis. 2022.

Snyder LR, Kirkland JJ, Dolan JW. Introduction to modern liquid chromatography. John Wiley & Sons, 2011.

Sonawane, S.S., Chhajed, S.S., Attar, S.S. et al. An approach to select linear regression model in bioanalytical method validation. Journal of Analytical Sciences and Technology. 2019; 10:1-7. https://doi.org/10.1186/s40543-018-0160-2.

Published
2023-02-28
How to Cite
1.
Notario D, Amelia J, Della G. Pengembangan dan Validasi Metode Bioanalisis Trimetoprim dalam Sampel Plasma dan Urin Manusia Simulasi Menggunakan KCKT-PDA. jki [Internet]. 28Feb.2023 [cited 28Apr.2024];13(1):41-9. Available from: http://ejournal2.litbang.kemkes.go.id/index.php/jki/article/view/6189